Clozapine for treatment‐resistant bipolar disorder: a systematic review

@article{Li2015ClozapineFT,
  title={Clozapine for treatment‐resistant bipolar disorder: a systematic review},
  author={Xian-Bin Li and Yi-lang Tang and Chuan-Yue Wang and Jos{\'e} De Leon},
  journal={Bipolar Disorders},
  year={2015},
  volume={17},
  pages={235 - 247}
}
To evaluate the efficacy and safety of clozapine for treatment‐resistant bipolar disorder (TRBD). 

An Update on the Diagnosis and Treatment of Bipolar Disorder, Part 1: Mania

This article reviews DSM-5 changes to symptom criteria for bipolar disorder. The primary focus is on the diagnosis and treatment of mania and hypomania.

Clozapine As Transformative Treatment In Bipolar Patients

Clozapine is an atypical antipsychotic used in treatment-resistant bipolar disorder and may become transformative treatment in bipolar disorder impacting the clinical course and psychosocial burden of the disease.

Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders

This study compared 29 drugs for risk of psychiatric hospitalization in bipolar disorders, addressing the evidence gap on the >50 drugs used by US patients for treatment.

How to treat mania

Evidence‐based treatment options for bipolar mania are reviewed and proposed tentative evidence‐based clinical suggestions regarding the management of a manic episode are proposed, especially regarding the choice of the proper mood stabilizer and antipsychotic medication.

Areas of controversy in neuroprogression in bipolar disorder

Clinical features and biological underpinnings related to neuroprogression in bipolar disorder (BD) and areas of controversy and future research in the field are discussed.

Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy

The case of a 46‐year‐old woman suffering from bipolar disorder of type I with mixed features with initial fronto‐temporal atrophy, who successfully responded to a combination of rivastigmine, clozapine, and oxcarbazepine.

Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review

A case of a clozapine-stabilized, treatment-resistant bipolar disorder patient with ovarian carcinoma requiring chemotherapy, and the clinical challenges are discussed.

Clozapine: promising treatment for suicidality in bipolar disorder.

Clozapine with its unique pharmacology, anti-aggressive and anti-impulsive properties is potentially an effective strategy for suicidality in bipolar disorder.

Effective and underprescribed: what about clozapine?

In schizophrenia, a serious psychiatric disease with regard to overall impairment of patients up to three-quarters will experience a relapse after their first episode and one-fifth is facing long-term symptoms often leading to disability and dramatically reduced quality of life and psychosocial outcome.

Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study

This study investigates the therapeutic efficacy and functional brain alterations associated with multi‐infusion ketamine augmentation in patients with TRBPD.
...

References

SHOWING 1-10 OF 133 REFERENCES

Treatment‐resistant bipolar depression: towards a new definition

The conceptual and operational definitions of treatment‐resistant bipolar depression are summarized and the evidence-based therapeutic options are reviewed to review the evidence‐ based therapeutic options.

[Clozapine in the treatment of refractory rapid cycling bipolar disorder].

A 42 years old man suffering from bipolar disorder I with rapid cycling, unresponsive to conventional therapy, was successfully treated with clozapine and this case suggests that clozAPine could be efficient in treating mania and preventing relapse in affective disorders.

Evidence‐based options for treatment‐resistant adult bipolar disorder patients

Poon SH, Sim K, Sum MY, Kuswanto CN, Baldessarini RJ. Evidence‐based options for treatment‐resistant adult bipolar disorder patients. Bipolar Disord 2012: 14: 573–584. © 2012 The Authors. Journal

Clozapine Treatment of Children and Adolescents with Bipolar Disorder and Schizophrenia: A Clinical Case Series

ABSTRACT Ten consecutive severely ill child and adolescent inpatients (aged 6–15 years), who had either multiple trials of typical neuroleptics and antimanic agents with inadequate symptom remissio...

Treatment-refractory, juvenile-onset bipolar affective disorder

A case of juvenile-onset bipolar affective disorder with a childhood history of attention-deficit hyperactivity disorder (ADHD) is presented, and clozapine was given, which succeeded in achieving remission.

Treatment-refractory, juvenile-onset bipolar affective disorder.

A case of juvenile-onset bipolar affective disorder with a childhood history of attention-deficit hyperactivity disorder (ADHD) is presented, and clozapine was given, which succeeded in achieving remission.

Combined ECT and clozapine in treatment-resistant mania.

A treatment-resistant manic patient failed to respond to conventional treatment, adjunctive olanzapine), clozapine, or ECT alone, but did respond to ECT combined with low dose clozAPine, which resulted in a remission over the 18-month period.

Clozapine in the Management of Bipolar and Schizoaffective Manic Episodes Resistant to Standard Treatment

A controlled trial of clozapine in treatment-resistant bipolar and schizoaffective manic episodes is indicated and the drug was used after the failure of standard antipsychotics and mood stabilisers.
...